Masahiro Iwasaku

Rebiopsy of non–small cell lung cancer patients with acquired resistance to epidermal growth factor receptor‐tyrosine kinase inhibitor

Akito Hata, Nobuyuki Katakami, Hiroshige Yoshioka et al. · Cancer · 2013 · 178 citations · Full text

ONO-7475, a Novel AXL Inhibitor, Suppresses the Adaptive Resistance to Initial EGFR-TKI Treatment in <i>EGFR</i> -Mutated Non–Small Cell Lung Cancer

Naoko Okura, Naoya Nishioka, Tadaaki Yamada et al. · Clinical Cancer Research · 2020 · 108 citations

Complex Mutations in the Epidermal Growth Factor Receptor Gene in Non-small Cell Lung Cancer

Akito Hata, Hiroshige Yoshioka, Shiro Fujita et al. · Journal of Thoracic Oncology · 2010 · 96 citations

Complex Mutations, Tumor Biology, Medicine +9

The role of the gut microbiome on the efficacy of immune checkpoint inhibitors in Japanese responder patients with advanced non-small cell lung cancer

Yuki Katayama, Tadaaki Yamada, Takayuki Shimamoto et al. · Translational Lung Cancer Research · 2019 · 87 citations · Full text

How Sensitive Are Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors for Squamous Cell Carcinoma of the Lung Harboring EGFR Gene–Sensitive Mutations?

Akito Hata, Nobuyuki Katakami, Hiroshige Yoshioka et al. · Journal of Thoracic Oncology · 2012 · 69 citations · Full text

Oncology, Squamous Cell Carcinoma, Medicine +8